Literature DB >> 24038023

Multiple productive immunoglobulin heavy chain gene rearrangements in chronic lymphocytic leukemia are mostly derived from independent clones.

Karla Plevova1, Hana Skuhrova Francova, Katerina Burckova, Yvona Brychtova, Michael Doubek, Sarka Pavlova, Jitka Malcikova, Jiri Mayer, Boris Tichy, Sarka Pospisilova.   

Abstract

In chronic lymphocytic leukemia, usually a monoclonal disease, multiple productive immunoglobulin heavy chain gene rearrangements are identified sporadically. Prognostication of such cases based on immunoglobulin heavy variable gene mutational status can be problematic, especially if the different rearrangements have discordant mutational status. To gain insight into the possible biological mechanisms underlying the origin of the multiple rearrangements, we performed a comprehensive immunogenetic and immunophenotypic characterization of 31 cases with the multiple rearrangements identified in a cohort of 1147 patients with chronic lymphocytic leukemia. For the majority of cases (25/31), we provide evidence of the co-existence of at least two B lymphocyte clones with a chronic lymphocytic leukemia phenotype. We also identified clonal drifts in serial samples, likely driven by selection forces. More specifically, higher immunoglobulin variable gene identity to germline and longer complementarity determining region 3 were preferred in persistent or newly appearing clones, a phenomenon more pronounced in patients with stereotyped B-cell receptors. Finally, we report that other factors, such as TP53 gene defects and therapy administration, influence clonal selection. Our findings are relevant to clonal evolution in the context of antigen stimulation and transition of monoclonal B-cell lymphocytosis to chronic lymphocytic leukemia.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24038023      PMCID: PMC3912964          DOI: 10.3324/haematol.2013.087593

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  43 in total

1.  IMGT/V-QUEST, an integrated software program for immunoglobulin and T cell receptor V-J and V-D-J rearrangement analysis.

Authors:  Véronique Giudicelli; Denys Chaume; Marie-Paule Lefranc
Journal:  Nucleic Acids Res       Date:  2004-07-01       Impact factor: 16.971

2.  [Biclonal or biphenotypic chronic lymphotic leukemia? An answer brought by the treatment].

Authors:  Céline Acker; Anne Staal; Cédric Aumont; Jacqueline Didion; Véronique Dorvaux; Yves Rio; Véronique Latger-Cannard
Journal:  Ann Biol Clin (Paris)       Date:  2011 May-Jun       Impact factor: 0.459

3.  Missense mutations located in structural p53 DNA-binding motifs are associated with extremely poor survival in chronic lymphocytic leukemia.

Authors:  Martin Trbusek; Jana Smardova; Jitka Malcikova; Ludmila Sebejova; Petr Dobes; Miluse Svitakova; Vladimira Vranova; Marek Mraz; Hana Skuhrova Francova; Michael Doubek; Yvona Brychtova; Petr Kuglik; Sarka Pospisilova; Jiri Mayer
Journal:  J Clin Oncol       Date:  2011-05-23       Impact factor: 44.544

Review 4.  Antigens in chronic lymphocytic leukemia--implications for cell origin and leukemogenesis.

Authors:  Anders Rosén; Fiona Murray; Chamilly Evaldsson; Richard Rosenquist
Journal:  Semin Cancer Biol       Date:  2010-09-21       Impact factor: 15.707

5.  The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia.

Authors:  Yair Herishanu; Patricia Pérez-Galán; Delong Liu; Angélique Biancotto; Stefania Pittaluga; Berengere Vire; Federica Gibellini; Ndegwa Njuguna; Elinor Lee; Lawrence Stennett; Nalini Raghavachari; Poching Liu; J Philip McCoy; Mark Raffeld; Maryalice Stetler-Stevenson; Constance Yuan; Richard Sherry; Diane C Arthur; Irina Maric; Therese White; Gerald E Marti; Peter Munson; Wyndham H Wilson; Adrian Wiestner
Journal:  Blood       Date:  2010-10-12       Impact factor: 22.113

6.  Immunoglobulin light chain repertoire in chronic lymphocytic leukemia.

Authors:  Kostas Stamatopoulos; Chrysoula Belessi; Anastasia Hadzidimitriou; Tatjana Smilevska; Evangelia Kalagiakou; Katerina Hatzi; Niki Stavroyianni; Anastasia Athanasiadou; Aliki Tsompanakou; Theodora Papadaki; Garyfallia Kokkini; George Paterakis; Riad Saloum; Nikolaos Laoutaris; Achilles Anagnostopoulos; Athanasios Fassas
Journal:  Blood       Date:  2005-08-02       Impact factor: 22.113

7.  Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis.

Authors:  Fiona Murray; Nikos Darzentas; Anastasia Hadzidimitriou; Gerard Tobin; Myriam Boudjogra; Cristina Scielzo; Nikolaos Laoutaris; Karin Karlsson; Fanny Baran-Marzsak; Athanasios Tsaftaris; Carol Moreno; Achilles Anagnostopoulos; Federico Caligaris-Cappio; Dominique Vaur; Christos Ouzounis; Chrysoula Belessi; Paolo Ghia; Fred Davi; Richard Rosenquist; Kostas Stamatopoulos
Journal:  Blood       Date:  2007-10-24       Impact factor: 22.113

8.  B cell receptor revision diminishes the autoreactive B cell response after antigen activation in mice.

Authors:  Ying-Hua Wang; Betty Diamond
Journal:  J Clin Invest       Date:  2008-08       Impact factor: 14.808

9.  Incidence and clinicobiologic characteristics of leukemic B-cell chronic lymphoproliferative disorders with more than one B-cell clone.

Authors:  Maria-Luz Sanchez; Julia Almeida; David Gonzalez; Marcos Gonzalez; Maria-Antonia Garcia-Marcos; Ana Balanzategui; Maria-Consuelo Lopez-Berges; Josep Nomdedeu; Teresa Vallespi; Marcos Barbon; Alejandro Martin; Pilar de la Fuente; Guillermo Martin-Nuñez; Javier Fernandez-Calvo; Jesus-Maria Hernandez; Jesus F San Miguel; Alberto Orfao
Journal:  Blood       Date:  2003-06-26       Impact factor: 22.113

10.  Single-cell analysis reveals oligoclonality among 'low-count' monoclonal B-cell lymphocytosis.

Authors:  M C Lanasa; S D Allgood; A D Volkheimer; J P Gockerman; J F Whitesides; B K Goodman; J O Moore; J B Weinberg; M C Levesque
Journal:  Leukemia       Date:  2009-10-15       Impact factor: 11.528

View more
  17 in total

1.  Chronic lymphocytic leukemia: from molecular pathogenesis to novel therapeutic strategies.

Authors:  Julio Delgado; Ferran Nadeu; Dolors Colomer; Elias Campo
Journal:  Haematologica       Date:  2020-07-02       Impact factor: 9.941

2.  Molecular and cytogenetic characterization of expanded B-cell clones from multiclonal versus monoclonal B-cell chronic lymphoproliferative disorders.

Authors:  Ana Henriques; Arancha Rodríguez-Caballero; Ignacio Criado; Anton W Langerak; Wendy G Nieto; Quentin Lécrevisse; Marcos González; Emília Cortesão; Artur Paiva; Julia Almeida; Alberto Orfao
Journal:  Haematologica       Date:  2014-01-31       Impact factor: 9.941

3.  Targeted deep sequencing reveals clinically relevant subclonal IgHV rearrangements in chronic lymphocytic leukemia.

Authors:  B Stamatopoulos; A Timbs; D Bruce; T Smith; R Clifford; P Robbe; A Burns; D V Vavoulis; L Lopez; P Antoniou; J Mason; H Dreau; A Schuh
Journal:  Leukemia       Date:  2016-10-31       Impact factor: 11.528

4.  Single-Cell Analysis and Next-Generation Immuno-Sequencing Show That Multiple Clones Persist in Patients with Chronic Lymphocytic Leukemia.

Authors:  Jitra Kriangkum; Sarah N Motz; Tanner Mack; Sara Beiggi; Eva Baigorri; Hemalatha Kuppusamy; Andrew R Belch; James B Johnston; Linda M Pilarski
Journal:  PLoS One       Date:  2015-09-09       Impact factor: 3.240

5.  Multiple productive IGH rearrangements denote oligoclonality even in immunophenotypically monoclonal CLL.

Authors:  K Brazdilova; K Plevova; H Skuhrova Francova; H Kockova; M Borsky; V Bikos; J Malcikova; A Oltova; J Kotaskova; B Tichy; Y Brychtova; J Mayer; M Doubek; S Pospisilova
Journal:  Leukemia       Date:  2017-08-29       Impact factor: 11.528

6.  Expression of COBLL1 encoding novel ROR1 binding partner is robust predictor of survival in chronic lymphocytic leukemia.

Authors:  Hana Plešingerová; Pavlína Janovská; Archana Mishra; Lucie Smyčková; Lucie Poppová; Antonín Libra; Karla Plevová; Petra Ovesná; Lenka Radová; Michael Doubek; Šárka Pavlová; Šárka Pospíšilová; Vítězslav Bryja
Journal:  Haematologica       Date:  2017-11-09       Impact factor: 9.941

Review 7.  Chronic Lymphocytic Leukemia B-Cell Normal Cellular Counterpart: Clues From a Functional Perspective.

Authors:  Walaa Darwiche; Brigitte Gubler; Jean-Pierre Marolleau; Hussein Ghamlouch
Journal:  Front Immunol       Date:  2018-04-04       Impact factor: 7.561

Review 8.  Immune Gene Rearrangements: Unique Signatures for Tracing Physiological Lymphocytes and Leukemic Cells.

Authors:  Michaela Kotrova; Nikos Darzentas; Christiane Pott; Claudia D Baldus; Monika Brüggemann
Journal:  Genes (Basel)       Date:  2021-06-27       Impact factor: 4.096

9.  Longitudinal copy number, whole exome and targeted deep sequencing of 'good risk' IGHV-mutated CLL patients with progressive disease.

Authors:  M J J Rose-Zerilli; J Gibson; J Wang; W Tapper; Z Davis; H Parker; M Larrayoz; H McCarthy; R Walewska; J Forster; A Gardiner; A J Steele; C Chelala; S Ennis; A Collins; C C Oakes; D G Oscier; J C Strefford
Journal:  Leukemia       Date:  2016-02-05       Impact factor: 11.528

10.  Evidence of shared epitopic reactivity among independent B-cell clones in chronic lymphocytic leukemia patients.

Authors:  S Mimmi; E Vecchio; E Iaccino; M Rossi; A Lupia; F Albano; F Chiurazzi; G Fiume; A Pisano; S Ceglia; M Pontoriero; G Golino; P Tassone; I Quinto; G Scala; C Palmieri
Journal:  Leukemia       Date:  2016-08-29       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.